Stereotaxis, Inc.
For the period ended Dec 31, 2024. Filed Mar 14, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 14, 2025
STXS$1.14+4.6%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Financial Statements and Supplementary Data
| ITEM 8. | CONSOLIDATED FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA |
|---|
Index To Consolidated Financial Statements
| PAGE | |
|---|---|
| Report of Ernst & Young LLP, Independent Registered Public Accounting Firm (PCAOB ID: 42) | 49 |
| Consolidated Balance Sheets at December 31, 2024 and 2023 | 51 |
| Consolidated Statements of Operations for the years ended December 31, 2024 and 2023 | 52 |
| Consolidated Statements of Convertible Preferred Stock and Stockholders’ Equity for the years ended December 31,2024 and 2023 | 53 |
| Consolidated Statements of Cash Flows for the years ended December 31, 2024 and 2023 | 54 |
| Notes to the Consolidated Financial Statements | 55 |
| Schedule II—Consolidated Valuation and Qualifying Accounts | 77 |
All other schedules have been omitted because they are not applicable, or the required information is shown in the Consolidated Financial Statements or the Notes thereto.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.